Hughes Nicola F, Fern Lorna A, Polanco Angela, Carrigan Chris, Feltbower Richard G, Gamble Ashley, Connearn Emily, Lopez Angela, Bisci Ellen, Pritchard-Jones Kathy
Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.
Cancer Clinical Trials Unit, University College London Hospitals, London, UK.
Res Involv Engagem. 2023 Aug 29;9(1):71. doi: 10.1186/s40900-023-00485-8.
In the United Kingdom, healthcare data is collected on all patients receiving National Health Service (NHS) care, including children and young people (CYP) with cancer. This data is used to inform service delivery, and with special permissions used for research. The use of routinely collected health data in research is an advancing field with huge potential benefit, particularly in CYP with cancer where case numbers are small and the impact across the life course can be significant. Patient and public involvement (PPI) exercise aims: Identify current barriers to trust relating to the use of healthcare data for research. Determine ways to increase public and patient confidence in the use of healthcare data in research. Define areas of research importance to CYP and their carers using healthcare data.
Young people currently aged between 16 and 25 years who had a cancer diagnosis before the age of 20 years and carers of a young person with cancer were invited to take part via social media and existing networks of service users. Data was collected during two interactive online workshops totalling 5 h and comprising of presentations from health data experts, case-studies and group discussions. With participant consent the workshops were recorded, transcribed verbatim and analysed using thematic analysis.
Ten young people and six carers attended workshop one. Four young people and four carers returned for workshop two. Lack of awareness of how data is used, and negative media reporting were seen as the main causes of mistrust. Better communication and education on how data is used were felt to be important to improving public confidence. Participants want the ability to have control over their own data use. Late effects, social and education outcomes and research on rare tumours were described as key research priorities for data use.
In order to improve public and patient trust in our use of data for research, we need to improve communication about how data is used and the benefits that arise.
在英国,会收集所有接受国民健康服务(NHS)护理的患者的数据,包括患癌症的儿童和年轻人(CYP)。这些数据用于为服务提供提供信息,并在获得特殊许可后用于研究。在研究中使用常规收集的健康数据是一个不断发展的领域,具有巨大的潜在益处,尤其是在患癌症的CYP群体中,因为病例数量较少,且对整个生命历程的影响可能很大。患者和公众参与(PPI)活动目标:确定当前与将医疗保健数据用于研究相关的信任障碍。确定提高公众和患者对在研究中使用医疗保健数据的信心的方法。使用医疗保健数据确定对CYP及其护理人员具有研究重要性的领域。
邀请目前年龄在16至25岁之间、20岁之前被诊断患有癌症的年轻人以及患癌症年轻人的护理人员通过社交媒体和现有的服务用户网络参与。在总共5小时的两次互动在线研讨会上收集数据,研讨会包括健康数据专家的演讲、案例研究和小组讨论。经参与者同意,对研讨会进行了录音、逐字转录并使用主题分析进行分析。
10名年轻人和6名护理人员参加了第一次研讨会。4名年轻人和4名护理人员返回参加第二次研讨会。对数据使用方式缺乏了解以及媒体的负面报道被视为不信任的主要原因。人们认为更好地就数据使用方式进行沟通和教育对于提高公众信心很重要。参与者希望能够对自己的数据使用拥有控制权。后期影响、社会和教育成果以及对罕见肿瘤的研究被描述为数据使用的关键研究重点。
为了提高公众和患者对我们将数据用于研究的信任,我们需要改进关于数据使用方式及其产生的益处的沟通。